Simple model of a metabolic cycle. X, substrate; P , product; I*, (continuous) input of label; C, rate of cycling; I, net flux of X to P; D, any Bux(es) diluting P (these may be irreversible fluxes, as here, or an exchange of P with a large unlabelled pool). This model may represent a single reversible reaction (e.g. transamination) or an 'energy-dissipating' cycle in which X+P and P-rX are catalysed by distinct enzymes. If the label is added in tracer amounts, so that its mass flux is negligible compared with J , isotopic flux ro X = I* + C x S p , isotopic flux from X = (J + C') x Sx.
where SX and Sp are the specific activities of X and P respectively.
In a sfeady-state these fluxes are equal, so that, hence, or, letting R = I*ISx, I* + C X S p = (J + C) X Sx, I*/Sx = I + c x (l-SpISx).
R = J + C X (1-SpISx).
Under steady-state conditions the isotopic fluxes which produce labelled X equal those which remove the label, so that there is no net labelling of X. This constraint enables a set of 'balanced' isotopic-flux equations to be written and then solved to yield the mass fluxes (i.e. reaction and pathway rates) in terms of the specific activities of the labelled intermediates (or carbon atoms) and the rate of supply of labelled precursor. Fig. 1 (which includes eqn (1)) shows how this approach can be applied to a system in which a product, P, can be either metabolized further or recycled to substrate X. The input of isotope, I*, may represent either the rate of isotope infusion into a precursor pool such as blood, or the net uptake of labelled blood-borne substrate by an organ. In the latter case, from the definition of specific activity:
amount of tracer per vol. arterial blood = ca x Sa, amount of tracer per vol. venous blood = cv x S,, where ca and cv are the concentrations of substrate in arterial and venous blood and Sa and S , their respective specific activities.
Therefore, rate of tracer uptake (I*) = blood flow X (Ca X S, -cv X S,).
In experiments to determine whole-body fluxes the function R (i.e. the rate of infusion of tracer divided by its blood specific activity; see Fig. 1 ) is often used as a measure of the flux of X, and is often referred to as an 'entry rate' or an 'irreversible loss rate'. However, eqn (2) (Fig. 1) shows that, if there is recycling of X (at a rate C ) , the value of R does not equal any of the fluxes in the system unless the specific activity of the product (SP) is
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either zero or is equal to the specific activity of the substrate (SX). In the former case (Sp = 0), X behaves as an 'irreversible tracer' and R measures the actual 'gross' flux, J + C:
in the latter case ( S p = SX) R measures the actual net flux (or irreversible loss rate), J . Therefore, if there is recycling of label, the value of S p relative to SX must be determined in order to evaluate the quantitative significance of measured values of R. For trans-organ studies (using eqn (2a)):
which is often simplified by assuming that the specific activity of the substrate in venous blood, Sv, is the same as that in the tissue, SX (although, since the venous flow may contain some material derived directly from the arterial flow, this simplifying assumption is not necessarily correct). With this assumption for R, eqn (2) (Fig. 1) becomes:
Since the net mass flux, J, = blood flow x (Ca -cv), this equation can be rearranged into:
This equation shows that the rate of cycling, C, can be measured by infusing singly-labelled (e.g. 14C) X or a suitable precursor of X, provided that (1) SP can be measured or calculated indirectly and (2) S p is less than Sv, i.e. the tracer in the product Pis 'diluted' relative to that in X. (In other words, the diluting flux, D, in Fig. 1 must not be zero.) As discussed later, measuring S p or eliminating it from equations analogous to eqn (3) can sometimes be quite difficult, and may preclude an accurate determination of the rate of cycling in vivo.
Measuring of X f P interconversions when both X and P can be sampled If the cycle product, P (Fig. l) , is experimentally accessible SP can be measured directly and the value of C then calculated from equations analogous to eqn (3). Furthermore, an additional isotopic balance equation for the labelling of P:
enables the diluting flux, D, to be calculated. Moreover, if a different label is introduced directly into P (so that I* for this label enters at P rather than X ) , two more distinct isotopic-balance equations for the labelling of X and P may be written, giving even more information about the fluxes in the system. This approach has been used by Tessari et al. (1985) to measure the rate of exchange (transamination) between leucine and its oxo(keto)-acid, 4-methyl-2-0x0-pentanoate (MOP) . In these investigations the whole-body pools of leucine and MOP were labelled simultaneously with different isotopes (e.g. [3H]leucine and [ 1-14C]MOP) and the four isotopic balance equations solved simultaneously to give the rate of exchange, C, and several related fluxes.
Measuring rates of cycling by labelling a large pool of substrate
If the amount of X (Fig. 1) is relatively large and label can be introduced directly into the product P then, for short incubation periods, the rate of cycling (C) can be measured as the rate of labelling of substrate X (which acts as a short-term isotope 'sink').
Although this is a pre-steady rather than a steady-state technique it has been used to measure cycling between pyruvate, oxaloacetate and phosphoenolpyruvate in rat liver (Rognstad, 1975; Katz & Rognstad, 1976 (Brooks et al. 1982 (Brooks et al. ,1983 .
Acetate-acetyl-CoA cycle in sheep muscle When P (Fig. 1) is a tissue intermediate which does not enter or have access to the blood, a direct determination of SP is usually not possible. However, in some cases, S p may be estimated indirectly, as with the substrate cycle between acetate and acetyl-CoA in sheep muscle (Crabtree et al. 1987) . This cycle (Fig. 2) occurs in the mitochondria of several mammalian tissues and also in the cytoplasm of rat liver where it is especially active (Rabkin & Blum, 1985; Jessop et al. 1986) . Its role in vivo is still unclear, but it may provide an acetate-controlled ATPase (EC 3.6.1.8) which would enable excess acetate to be oxidized rather than stored as fat. Its activity in sheep muscle in vivo was first estimated by Pethick et al. (1981) and has been studied in more detail since (Crabtree et al. 1987) . Isotope input into the muscle was by arterio-venous uptake after infusing a singly-labelled substrate ([ 1-l4C]acetate) into a jugular vein. Dilution of the cycle product, acetyl-CoA (equivalent to P in Fig. 1) . was provided by the oxidation of unlabelled fuels, e.g. glucose, fatty acids and ketone bodies. Since S p refers, in this example, to the specific activity of mitochondrial acetyl-CoA (Sacctyl-CoA), it would be difficult if not impossible to measure it directly in vivo. However, in muscle the value of Sacetyl-CoA can be estimated by assuming that acetate labels a single pool of mitochondria1 acetyl-CoA which participates in only two reactions: condensation with oxaloacetate in the tricarboxylic acid cycle ( K ) and recycling to acetate (C). (It must be stressed that in other tissues, especially liver and adipose tissue, these assumptions are not valid.) VOl. 47 The resulting derivations are shown in Fig. 2 (Fig. 2 also includes eqn (4) ). The calculated acetate-acetyl-CoA cycling rate, C, is low and apparently not much influenced by increasing the blood acetate concentration ( Table 1 ); suggesting that a direct effect of acetate on this particular cycle in muscle is of minimal importance in disposing of excess acetate. (In contrast, the same cycle in liver may be much more important (Jessop et al. 1986) .) It should also be noted that, if the labelling of acetyl-CoA is not taken into account, the rate of cycling may be underestimated by as much as three-to fourfold ( Table 1) .
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Measuring cycling or reversible-exchange rates using a substrate labelled with two different isotopes As will be appreciated from the previous comments, a major problem with using a single isotope is the need to measure or estimate the specific activity of the cycle product (Sp). Moreover, if the tracer in the product Pis not diluted relative to that in X (i.e. if S p = SX) then the method cannot be used to estimate cycling at all. These problems may be surmounted by eliminating 'SP' from the equations by labelling X with isotopes which are metabolized differently during the appropriate reactions. For example, if one isotope is completely diluted (or exchanged, or both) at P (so that S p = 0) while the other is not diluted at all (so that SP = SX), the two respective 'R values' (R(') and R(*)) will equal J + C and J respectively ( Fig. 1) : their difference will thus equal C, the cycling rate.
This simple method has been used to measure the rate of Cori (lactate) and alanine cycling between blood glucose and lactate-pyruvate-alanine ( Fig. 3; see Katz & Rognstad, 1976; Schulman et al. 1985) . In this case [14C]glucose provides a label which is not exchanged in the metabolic transformations whereas [6-3H]glucose provides one that is almost completely lost by exchange at lactate-pyruvate. Thus,
Use of mass-cluster analysis. An interesting extension of the previously described approach is based on the ability to separate and measure stable isotopes of glucose according to their mass (Tserng & Kalhan, 1983b molecules is small compared with the total body pool it is highly unlikely that, during the reverse reaction of the Cori cycle (i.e. gluconeogenesis), two ' m + 3' molecules will meet and recombine to give an ' m + 6' hexose. The 'm + 6' glucose thus behaves as an irreversible tracer (analogous to [6-3H]glucose) and, by measuring the values of 'R' for both this species and the C-1 atom of glucose (which provides a label analogous to
[14C]glucose), the rate of cycling can be obtained by difference (Tserng & Kalhan, 1983b) .
A similar example is the use of [l-13C, 15N]leucine to measure (amongst other things) the transamination exchange between leucine and MOP mentioned earlier. Since the probability of doubly-labelled leucine being reformed is very low, this species serves as an irreversible tracer for the gross flux (J + C) of leucine to MOP. Application of this method to the human forearm (which is predominantly muscle) has revealed how sensitive protein metabolism, leucine transamination and MOP decarboxylation are to nutritional state (Cheng et af. 1985 (Cheng et af. , 1987 ; see Table 2 ) . ISN] leucine. In principle the transamination exchange betwecn leucine and MOP was calculated from the difference between net flux ( J , Fig. 1) . assessed by movement of label, and total flux (I + C, Fig. 1) .
assessed by the movement of 15N isotope. Oxidation was based on the production of I3CO2, while protein synthesis and degradation were calculated from net isotope and mass movement) This type of 'mass cluster' analysis has no counterpart in radioisotopic analysis (in which isotopes can only be distinguished by their energy spectra; which would be identical for the 'm + 3' and 'm + 6' species of [14C]glucose). It can therefore provide kinetic information that is unobtainable by using radioactive isotopes alone; and may be of great value in future investigations of complex systems, for example those which occur in association with the tricarboxylic acid cycle.
Substrate cycles associated with glucose metabolism. 3H-labelled glucose has also been used to measure the rates of two important substrate cycles associated with glycolysis: between glucose and glucose-6-phosphate (G6P) and between fructose-6-phosphate (F6P) and fructose-l,6-bisphosphate (FBP) (Fig. 4) . These cycles may be important in providing sensitivity for control and, since they are accompanied by ATP hydrolysis, they may also serve to control heat production and the disposal of 'excess' nutrients (see Newsholme & Crabtree, 1976 1986 ). It relies on the exchange of 3H from C-2 of glucose during the interconversion of G6P and F6P, and exchange from C-3 or C-5 during the interconversions of triose phosphates. These exchanges lead to a loss of 3H from the respective cycle products, G6P and F6P. Therefore, by analogy with the Cori-alanine cycles, [2-3H]glucose and [3-3H]glucose have been used as 'irreversible' tracers to measure the 'gross flux' (J + C) across the glucoseSi6P and F6P-Fl3P cycles respectively, in liver in vivo. The value of C was then obtained by subtracting the R function for [6-3H]glucose which, as discussed earlier, measures the net glycolytic flux, J (Karlander et al. 1986) . A similar study, using stable isotopes (ZD, 3 -~-and 6,6,~~-glucose), has shown that thyroid hormones may affect the rates of both cycles (Schulman et al. 1985) .
Unfortunately, these studies do not provide accurate measurements of substrate cycling in vivo for at least three reasons. First, [6-3H] glucose measures the rate of glycolysis in all tissues, whereas the glucose46P cycle operates principally if not exclusively in the liver. Second, only the liver F6P-FBP cycle will affect the 'R'value for blood [3-3H] glucose because most extrahepatic tissues lack G6Pase (EC 3.1.3.9) activity and hence cannot transmit a loss of 3H from their hexose phosphate pool back to blood glucose; thus muscle F6P-FBP cycling will not be detected. Consequently, the rates of both these cycles will be underestimated by subtracting the R function for blood [6-3H] glucose (i.e. the total glycolytic flux of many tissues) from that for blood [2-3H]-or [3-3H]glucose (which refers only to the fluxes in liver). Third, as the investigators with S2 zero) = G(100-S1)/S1, where G is the rate of lactate production and 51, S2 are expressed as percentages of the 3H:14C ratio of the administered glucose. These equations, derived specifically for this cycle by Newsholme & Crabtree (1976) , may be deduced from eqn (5) (see below) by noting that I is equivalent to G and R is the rate of labelling of hexose phosphate from glucose divided by the specific radioactivity (SRA) of hexose phosphate. Thus:
themselves recognized, the loss of 3H from G6P and FBP is almost certainly incomplete, i.e. Sp>O (see Katz & Rognstad, 1976) , and neglecting this leads to a further underestimation of the rate of cycling (Newsholme & Crabtree, 1976) . For example, in isolated muscle, as much as 70% of the 3H in FBP can be retained and this may introduce errors of nearly fourfold in the rate of cycling (i.e. 0.22 v . 0.06 Fmolh per g; Table 3 ). A consequence of this particular underestimation is that the contributions to thermogenesis in vivo of F6P-FBP cycling in both the flight muscles of bumble bees (Clark et al. 1973a) and in malignant hyperthermic pig muscle (Clark et al. 19736 ) may be much greater than reported. For example, the contribution of the F6P-FBP cycle to the increased heat production in hyperthennic pigs, calculated as 10-20% by Katz & Rognstad (1976) , could be as much as 4040% if the retention of 3H in FBP is similar to that in rat muscle (Table 3) . Use of isotope ratios in the product, P, to measure cycling. Since isotope may be only partially exchanged, we must consider the general situation where Sp>O and Sp=Sx. For each of two differently-metabolized labels (1 and 2) the solutions of eqn (2) (Fig. 1) are:
By setting a = [S~/SPI]/[SXZ/SXI] so that a = [ratio of isotope 2:isotope 1 in a sample of P]/[ratio of isotope 2:isotope 1 in a sample of XI,
Combining this with the equation for R(') gives at https:/www.cambridge.org/core/terms. https://doi.org/10.1079/PNS19880054
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An advantage of this approach is that only the ratio of the two isotopes in the product needs to be determined and not their individual specific activities. Thus, when samples are limited (e.g. with tissue biopsies), camer metabolites can be added to facilitate purification (although, with stable isotopes, the small amounts of isotope present in the camer must be allowed for). Another advantage is that any intracellular dilutions of X o r P will affect both isotopes equally, so that the isotope ratio, and hence the value of a, is unchanged (although such dilutions of X may give rise to erroneous values for 'R'; see below).
Eqn ( 5 ) is quite general and may be applied to a whole-body cycle (where R is the rate of infusion of isotope divided by SX), a cycle in a defined organ or tissue region (where R is blood flow multiplied by (c& -cvSv)/Sv), or a cycle in an isolated tissue. For example, by using glucose labelled with 14C at C-6, and 3H on C-5, this equation (although not explicitly in the form given here) has been used to calculate the rate of F6P-FBP cycling in isolated rat muscles (see Table 3 ).
Since eqn (5) gives only the 'gross uptake', (J + C), to obtain C it is usually necessary to measure the net flux, J, by an alternative procedure (for example, in Table 3 the net flux, G, was measured as the rate of lactate production). For trans-tissue measurements/ is the net mass uptake; obtained as the product of blood flow and arterio-venous concentration difference. For whole-body kinetics J must be measured by using an alternative label; for example, the use of [6-3H] glucose to measure the net glycolytic flux, i.e. 'S, for substrate cycling in vivo between glucose and G6P, and between F6P and FBP.
Some problems which may be encountered when measuring cycling with tracers At least three important points must be considered when using tracers to measure cycling rates. First, there must be no loss of label from Xcaused by factors other than the cycle. For example, in liver an active transaldolase (EC 2.2.1.2) catalyses an exchange of C-4-C-6 of G6P with triose phosphate, with a consequent loss of 3H from C-5 of hexose phosphate. Therefore, [5-3H] glucose cannot be used to measure F6P-FBP cycling in liver. Although [3-3H] glucose is not affected by this particular problem, false values for cycling may still be obtained with this labelled species if the rate of the pentose phosphate cycle is high (see Katz & Rognstad, 1976) . However, in muscle there is little, if any, transaldolase activity (Challis, 1983) and the rate of the pentose phosphate cycle is extremely low; so that either of these tritiated glucoses may be confidently used to measure the F6P-FBP cycle in that tissue. Indeed, the use of [6-14C]: [5-3H] gl~~~se to measure this cycle in muscle has been validated by comparison with a single-isotope technique in which [6-14C]glucose was added to a muscle preparation and the rate of F6P-FBP cycling calculated from the [1-14C]:[6-14C] ratios in FBP and hexose phosphates (Challis et al. 19846) .
Second, there must be a rapid and reversible exchange of the intracellular and extracellular pools of the substrate, X, i.e. these two pools must be in near-equilibrium. If this is not so, any dilution of labelled X (or decrease in its specific activity due to cycling) in the cell will not be reflected in the specific activity of X in the sampling pool (i.e. blood, cell culture or incubation medium). The specific activity in the sampling pool will then be greater than that in the cell and hence the value of 'R' will be underestimated (see eqns (1) and (2) in Fig. 1 ). This problem may be difficult to resolve (or even detect) and is exemplified by the difficulties of deciding which specific activity best represents the precursor pool for protein synthesis (see Waterlow et al. 1978) . Moreover, the assumption that S X = S,, made when deriving eqn (3), only applies when there is a rapid exchange between the extracellular and intracellular pools of X. Indeed, in the extreme situation where the uptake of X is totally irreversible, changes of SX in the cell will not be communicated to X in the sampling pool at all, so that any intracellular cycling between X and P ( Fig. 1) would not even be detected by measuring SX in the sampling (extracellular) pool. (As mentioned earlier, the irreversibility of glucose uptake and phosphorylation in muscle prevents substrate cycling between F6P and FBP in this tissue from being detected using blood [3-3H]glucose in vivo.) Third, if P is an intermediate which occurs in more than one intracellular compartment, or if significant channelling of P occurs (see Srivastava & Bernhard, 1986) , the overall tissue isotope ratio (a) may not reflect that at the intracellular site of the reaction of interest. It may often be difficult to overcome this particular problem, but a possible specific solution is given in the next section.
Use one oxygen atom of the carboxyl group (i.e. half the total 0) is lost to water. This loss is essentially irreversible, because the probability of a carboxyl-derived lAO atom being returned from water to acetate during the subsequent hydrolysis of acetyl-CoA (see Fig.  2) is extremely low. Consequently, it is reasonable to assume that, for acetate labelled with 13C and l80, the value of a (i.e. lSO:l3C ratio of acetyl-CoA relative to acetate) is 0.5. Eqn (5) then reduces to, Since a does not need to be measured, complications arising from the nature of the acetyl-CoA compartment do not arise. However, it would be essential to ensure that exchange of l80 with water-0 does not occur during extraction or analysis of the acetate; or even during the synthetase reaction.
A similar approach using [14C]-and [2,3-side-chain3H]tyrosine has been used to measure the extent of transamination-reamination that occurs with tyrosine in rabbit tissues (Nicholas et af. 1977) . During transamination the H atom at C-2 (i.e. half the 3H label) is lost, so that exactly the same analysis can be applied as for [180:13C] acetate.
Conclusions
Although we have discussed relatively simple examples, the general approach of writing and solving a set of isotopic-'balance' equations for each intermediate can be readily extended to more complicated systems (see Nolan er al. 1976; Katz & Grunnet, 1979; Blum & Stein, 1982) . Experiments involving isotope infusions or incubations can, therefore, provide considerable information about complex metabolic fluxes in vivo, especially if several different isotopes are used (e.g. Egan et al. 1983; Rabkin & Blum, 1985) . Even more information can be obtained by measuring the isotopic activities of the individual atoms of the metabolic intermediates (see Wiltrout & Satter, 1972; Williams et al. 1987 ), but, until recently, this always required chemical or enzymic degradations, or both, which can be inaccurate and time-consuming. However, newer techniques (especially nuclear magnetic resonance) now allow the distribution of stable isotopes in several intermediates to be measured without degrading the molecules, thereby making valuable additional kinetic information more readily accessible (e.g. Cohen et al. 1979; Cohen, 1983 Cohen, , 1987 Pahl-Wostl & Seelig, 1986; Malloy et al. 1987) . These newer approaches offer exciting possibilities for future investigations. However, it must always be remembered that they rely on the same basic principles as (and share many potential at https:/www.cambridge.org/core/terms. https://doi.org/10.1079/PNS19880054
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Measurement of metabolic regulation 363 pitfalls with) conventional tracer techniques which, in our opinion, will continue to play a major role in metabolic research for the foreseeable future.
